Results 171 to 180 of about 61,852 (229)
Oncologic Benefits and Cardiovascular Risks of Pembrolizumab: Insights From a Nationwide Lung Adenocarcinoma Cohort. [PDF]
Park CS +9 more
europepmc +1 more source
Avoiding Diagnostic Anchoring: The Case for Systematic Evaluation of Pericardial Disease. [PDF]
Vincent J, Vakamudi S.
europepmc +1 more source
Pericardial Diseases in Cardiovascular Medicine: Contemporary Diagnosis, Risk Stratification, Multimodality Imaging, and Targeted Anti-Inflammatory Therapy. [PDF]
Kim BS, Hwang JW.
europepmc +1 more source
Diagnostic Yield of Routine Pericardial Fluid Cultures and Clinical Predictors of Bacterial Pericarditis. [PDF]
Orlev A +4 more
europepmc +1 more source
Tuberculous Pericarditis [PDF]
Background— The incidence of tuberculous pericarditis is increasing in Africa as a result of the human immunodeficiency virus (HIV) epidemic. The primary objective of this article was to review and summarize the literature on the pathogenesis, diagnosis, and management
Bongani Mayosi, Anton F Doubell
exaly +5 more sources
Risk of Constrictive Pericarditis After Acute Pericarditis [PDF]
Background-Constrictive pericarditis (CP) is considered a rare, dreaded possible complication of acute pericarditis. Nevertheless, there is a lack of prospective studies that have evaluated the specific risk according to different etiologies.
Massimo Imazio +2 more
exaly +3 more sources

